Benzinga | May 6, 2021 04:38PM EDT

Celldex Therapeutics Q1 EPS $(0.42) Up From $(0.73) YoY, Sales $685.00K Down From $2.73M YoY

Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.42) per share. This is a 42.47 percent increase over losses of $(0.73) per share from the same period last year. The company reported $685.00 thousand in sales this quarter. This is a 74.89 percent decrease over sales of $2.73 million the same period last year.